FDA 1572 Statement of Investigator - ccrod cancer-2025

Get Form
form fda 1572 statement of investigator is legally binding between the investigator and the Preview on Page 1

Here's how it works

01. Edit your form fda 1572 statement of investigator is legally binding between the investigator and the online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send statement of investigator via email, link, or fax. You can also download it, export it or print it out.

How to edit FDA 1572 Statement of Investigator - ccrod cancer in PDF format online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

Working on documents with our feature-rich and user-friendly PDF editor is simple. Make the steps below to fill out FDA 1572 Statement of Investigator - ccrod cancer online easily and quickly:

  1. Sign in to your account. Log in with your credentials or create a free account to test the product prior to upgrading the subscription.
  2. Upload a form. Drag and drop the file from your device or add it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
  3. Edit FDA 1572 Statement of Investigator - ccrod cancer. Quickly add and highlight text, insert images, checkmarks, and signs, drop new fillable fields, and rearrange or remove pages from your paperwork.
  4. Get the FDA 1572 Statement of Investigator - ccrod cancer completed. Download your modified document, export it to the cloud, print it from the editor, or share it with other participants using a Shareable link or as an email attachment.

Take advantage of DocHub, the most straightforward editor to promptly handle your documentation online!

See more FDA 1572 Statement of Investigator - ccrod cancer versions

We've got more versions of the FDA 1572 Statement of Investigator - ccrod cancer form. Select the right FDA 1572 Statement of Investigator - ccrod cancer version from the list and start editing it straight away!
Versions Form popularity Fillable & printable
2019 4.9 Satisfied (21 Votes)
2016 4.4 Satisfied (225 Votes)
2013 4.3 Satisfied (81 Votes)
2013 4.8 Satisfied (38 Votes)
2006 4 Satisfied (54 Votes)
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
The FDA Form 1572 must be filed when there is an addition of a new investigator to a clinical trial team. It does not require updating for annual reports or protocol amendments unless a new investigator is introduced. Thus, the answer is B: Addition of a new investigator.
The Form FDA 1572/DAIDS IoR Form must list all IRBs/ECs/REs/Approving Entity(ies) that are responsible for the review and approval of a clinical trial at a CRS prior to the CRSs initiation of the protocol.
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial.
The investigator is required to attach either a Curriculum Vitae (CV) or Other Statement of Qualifications showing the education, training and experience that qualifies the investigator as an expert in the clinical investigation of the drug/biologic for the use under investigation.
21 CFR 312.60 An investigator is responsible for ensuring that an investigation is conducted ing to the signed investigator statement (the FDAs 1572 form), the investigational plan, and applicable regulations; for protecting the rights, safety, and welfare of subjects under the investigators care; and for the
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

The site investigator is responsible for updating his/her 1572 form and providing it to the sponsor in a timely manner so the information can be sent to the FDA.
A form that must be filed by an investigator running a clinical trial to study a new drug or agent.

Related links